TrialThe oncologist2026

Phase II study of maintenance trifluridine/tipiracil (TAS-102) plus bevacizumab after induction chemotherapy in metastatic colorectal cancer.

Katsuya Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.